Coherus Oncology Inc.

NASDAQ: CHRS
Share price (8/14/25): $1.02
Market cap (8/14/25): $119 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Indentures Filter

from 8-K 4 pages First Supplemental Indenture

from 10-K 43 pages License Agreement

from S-3 52 pages Coherus Biosciences, Inc. Indenture Dated as of , 20___ [ ] Trustee

from 10-Q ~1 page [***] Certain Information in This Exhibit Has Been Omitted Because It Is Permitted to Be Omitted by Applicable Regulatory Guidance.

from 8-K 97 pages Coherus Biosciences, Inc. and U.S. Bank National Association as Trustee Indenture Dated as of April 17, 2020 1.500% Convertible Senior Subordinated Notes Due 2026

from 10-K 4 pages Description of Coherus’ Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 8-K 23 pages Coherus Biosciences, Inc. Registration Rights Agreement

from 8-K 25 pages Coherus Biosciences, Inc. Registration Rights Agreement

from S-3 51 pages Coherus Biosciences, Inc. Indenture Dated as of , 20 [ ] Trustee

from 8-K 25 pages Coherus Biosciences, Inc. Registration Rights Agreement

from S-1/A 2 pages Indenture or similar

from S-1 67 pages Coherus Biosciences, Inc. Third Amended and Restated Investor Rights Agreement

from DRS 67 pages Coherus Biosciences, Inc. Third Amended and Restated Investor Rights Agreement